These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6296362)

  • 1. Alterations of the [59Fe]ferric citrate biodistribution in hyperferremic mice after the administration of pyrophosphate and desferrioxamine.
    Sawas-Dimopoulou C; Soulpi C
    J Pharmacol Exp Ther; 1983 Feb; 224(2):415-8. PubMed ID: 6296362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP; Porter JB
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    J Lab Clin Med; 2001 Aug; 138(2):130-8. PubMed ID: 11477380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking action of parenteral desferrioxamine on iron absorption in rodents and men.
    Levine DS; Huebers HA; Rubin CE; Finch CA
    Gastroenterology; 1988 Nov; 95(5):1242-8. PubMed ID: 3169492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S; Bomford A
    Biochem J; 1988 Sep; 254(3):869-75. PubMed ID: 3196300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of deferoxamine on ferric chloride-induced epilepsy in rats.
    Zou X; Jiang S; Wu Z; Shi Y; Cai S; Zhu R; Chen L
    Brain Res; 2017 Mar; 1658():25-30. PubMed ID: 28063856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus.
    de Locht M; Boelaert JR; Schneider YJ
    Biochem Pharmacol; 1994 May; 47(10):1843-50. PubMed ID: 8204101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paramagnetic pyrophosphate. Preliminary studies on magnetic resonance contrast enhancement of acute myocardial infarction.
    Maurer AH; Knight LC; Siegel JA; Elfenbein IB; Adler LP
    Invest Radiol; 1990 Feb; 25(2):153-63. PubMed ID: 2155882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cellular iron concentration on iron uptake by hepatocytes.
    Trinder D; Batey RG; Morgan EH; Baker E
    Am J Physiol; 1990 Oct; 259(4 Pt 1):G611-7. PubMed ID: 2221071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation.
    Paller MS; Hedlund BE
    Free Radic Biol Med; 1994 Dec; 17(6):597-603. PubMed ID: 7532608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different actions of deferoxamine and iron on Ga-67 abscess detection in rats.
    Oberhaensli RD; Mueller RM; Fridrich R
    J Nucl Med; 1984 Jun; 25(6):668-72. PubMed ID: 6587029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte activation, iron uptake and release by human mononuclear leukocytes in the presence of desferrioxamine.
    Taylor PG; Soyano A; Romano E; Layrisse M
    Immunopharmacol Immunotoxicol; 1988; 10(2):165-78. PubMed ID: 3171105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell.
    Richardson DR
    Eur J Biochem; 2000 Mar; 267(5):1290-8. PubMed ID: 10691965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells.
    Richardson DR; Baker E
    Biochim Biophys Acta; 1992 Jan; 1103(2):275-80. PubMed ID: 1543713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-acting parenteral iron chelator, hydroxyethyl starch-deferoxamine, fails to protect against alcohol-induced liver injury in rats.
    Sadrzadeh SM; Hallaway PE; Nanji AA
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1038-42. PubMed ID: 9023321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of iron chelators on placental uptake and transfer of iron in rat.
    Wong CT; McArdle HJ; Morgan EH
    Am J Physiol; 1987 May; 252(5 Pt 1):C477-82. PubMed ID: 3578500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.